FdaApplication
NDA 021190
Identifiers
- fda_app_no: NDA021190
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE |
| application_type | NDA |
| approval_date | 2000-12-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUSPAR | BUSPIRONE HYDROCHLORIDE | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| BUSPAR | BUSPIRONE HYDROCHLORIDE | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| BUSPAR | BUSPIRONE HYDROCHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| BUSPAR | BUSPIRONE HYDROCHLORIDE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
4 products